Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jai Rautela

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Cancer Research|September 17, 2014
BMP4 inhibits breast cancer metastasis by blocking myeloid-derived suppressor cell activityYuan Cao, Clare Y Slaney, Bradley N Bidwell, et al.
Oncotarget|August 27, 2015
Cysteine cathepsin activity suppresses osteoclastogenesis of myeloid-derived suppressor cells in breast cancerLaura E Edgington-Mitchell, Jai Rautela, Hendrika M Duivenvoorden, et al.
Clinical & Translational Immunology|May 6, 2024
Optimisation of a primary human CAR-NK cell manufacturing pipelineAline Pfefferle, Julian Contet, Kahlia Wong, et al.
Immunology and Cell Biology|October 19, 2023
CD45 limits early Natural Killer cell developmentLizeth G Meza Guzman, Craig D Hyland, Grace M Bidgood, et al.
Frontiers in Immunology|February 22, 2020
NK Cell Priming From Endogenous Homeostatic Signals Is Modulated by CISRebecca B Delconte, Geoffrey Guittard, Wilford Goh, et al.
Cancer Immunology Research|August 30, 2017
Neoadjuvant Interferons: Critical for Effective PD-1-Based Immunotherapy in TNBCNatasha K Brockwell, Katie L Owen, Damien Zanker, et al.
Cell Death and Differentiation|October 9, 2019
miR17~92 restrains pro-apoptotic BIM to ensure survival of haematopoietic stem and progenitor cellsKerstin Brinkmann, Ashley P Ng, Carolyn A de Graaf, et al.
Frontiers in Immunology|September 14, 2018
GM-CSF Quantity Has a Selective Effect on Granulocytic vs. Monocytic Myeloid Development and FunctionLi Sun, Jai Rautela, Rebecca B Delconte, et al.
Molecular Immunology|August 27, 2018
Generation of novel Id2 and E2-2, E2A and HEB antibodies reveals novel Id2 binding partners and species-specific expression of E-proteins in NK cellsJai Rautela, Laura F Dagley, Tobias Kratina, et al.
Blood|September 20, 2018
IMiDs prime myeloma cells for daratumumab-mediated cytotoxicity through loss of Ikaros and AiolosPasquale L Fedele, Simon N Willis, Yang Liao, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Cancer Research|September 17, 2014
BMP4 inhibits breast cancer metastasis by blocking myeloid-derived suppressor cell activityYuan Cao, Clare Y Slaney, Bradley N Bidwell, et al.
Oncotarget|August 27, 2015
Cysteine cathepsin activity suppresses osteoclastogenesis of myeloid-derived suppressor cells in breast cancerLaura E Edgington-Mitchell, Jai Rautela, Hendrika M Duivenvoorden, et al.
Clinical & Translational Immunology|May 6, 2024
Optimisation of a primary human CAR-NK cell manufacturing pipelineAline Pfefferle, Julian Contet, Kahlia Wong, et al.
Immunology and Cell Biology|October 19, 2023
CD45 limits early Natural Killer cell developmentLizeth G Meza Guzman, Craig D Hyland, Grace M Bidgood, et al.
Frontiers in Immunology|February 22, 2020
NK Cell Priming From Endogenous Homeostatic Signals Is Modulated by CISRebecca B Delconte, Geoffrey Guittard, Wilford Goh, et al.
Cancer Immunology Research|August 30, 2017
Neoadjuvant Interferons: Critical for Effective PD-1-Based Immunotherapy in TNBCNatasha K Brockwell, Katie L Owen, Damien Zanker, et al.
Cell Death and Differentiation|October 9, 2019
miR17~92 restrains pro-apoptotic BIM to ensure survival of haematopoietic stem and progenitor cellsKerstin Brinkmann, Ashley P Ng, Carolyn A de Graaf, et al.
Frontiers in Immunology|September 14, 2018
GM-CSF Quantity Has a Selective Effect on Granulocytic vs. Monocytic Myeloid Development and FunctionLi Sun, Jai Rautela, Rebecca B Delconte, et al.
Molecular Immunology|August 27, 2018
Generation of novel Id2 and E2-2, E2A and HEB antibodies reveals novel Id2 binding partners and species-specific expression of E-proteins in NK cellsJai Rautela, Laura F Dagley, Tobias Kratina, et al.
Blood|September 20, 2018
IMiDs prime myeloma cells for daratumumab-mediated cytotoxicity through loss of Ikaros and AiolosPasquale L Fedele, Simon N Willis, Yang Liao, et al.
Pageof 5